Ophthotech Corp.

OPHT

Statistics

$2.98Share Price
$107 MMarket Cap
104.5%EBIT / EV
N/AFCF / EV
5102.3%ROIC
N/ACash ROIC
7.9%3yr Avg Revenue Growth
12.88Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

check mark The EBIT / Enterprise Value of 104.5% ranks as Suspicious.
x mark Cannot calculate Free Cash Flow / Enterprise Value, company has negative Free Cash Flow.
check mark The Return on Invested Capital Value of 5102.3% ranks as Suspicious.
x mark Cannot calculate Cash Return on Invested Capital, company has negative Free Cash Flow.
check mark The 3 Year Average Revenue Growth Value of 7.9% ranks as Above Average.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 12.88.

Company Description

Ophthotech Corp. operates as a biopharmaceutical company. It focuses on discovering, developing and commercializing novel therapeutics to treat diseases of the back of the eye. It develops therapies for age-related macular degeneration. Its product candidates include Fovista Anti platelet derived growth factor Therapy, Zimura Anti-Complement and Aptamer Technology. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in New York, NY.

Calculations

You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.
Tracking Portfolios
blue wand Magic Recipe 29.36%
purple wand Deep Value 24.71%
orange wand Quality Growth 44.22%
green wand Green Team 6.14%
red dot Red Rating 5.76%
yellow dot Yellow Rating 14.17%
green dot Green Rating 14.95%
New Spell Stocks
blue wand Vector Group Ltd. (VGR)
purple wand New Stocks Added!